当前位置: 首页 >> 检索结果
共有 3428 条符合本次的查询结果, 用时 1.9891999 秒

441. Author reply to: Increased Incidence of GERD in GLP-1 treated patients - fact or artefact?

作者: Benjamin Douglas Liu.;Gengqing Song.
来源: Gut. 2024年73卷9期1596页

442. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.

作者: Rui Li.;Xuefei Liu.;Xudong Huang.;Di Zhang.;Ziming Chen.;Jialiang Zhang.;Ruihong Bai.;Shaoping Zhang.;Hongzhe Zhao.;Zilan Xu.;Lingxing Zeng.;Lisha Zhuang.;Shujuan Wen.;Shaojia Wu.;Mei Li.;Zhixiang Zuo.;Junzhong Lin.;Dongxin Lin.;Jian Zheng.
来源: Gut. 2024年73卷3期470-484页
Metastasis is the major cause of cancer death. However, what types of heterogenous cancer cells in primary tumour and how they metastasise to the target organs remain largely undiscovered.

443. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.

作者: Jiaying Zhu.;Chuqing Sun.;Min Li.;Guoru Hu.;Xing-Ming Zhao.;Wei-Hua Chen.
来源: Gut. 2024年73卷7期1087-1097页
We aim to compare the effects of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) on the gut microbiota through longitudinal analysis.

444. Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study.

作者: Albert J Bredenoord.;Evan S Dellon.;Ikuo Hirano.;Alfredo J Lucendo.;Christoph Schlag.;Xian Sun.;Lila Glotfelty.;Leda Mannent.;Jennifer Maloney.;Elizabeth Laws.;Eric Mortensen.;Arsalan Shabbir.
来源: Gut. 2024年73卷3期398-406页
To assess the effect of long-term dupilumab on histological, symptomatic and endoscopic aspects of eosinophilic oesophagitis (EoE) in adolescent and adult patients with and without prior use of swallowed topical corticosteroids (STC) or prior inadequate response, intolerance or contraindication to STC.

445. Correction: Mucus barrier, mucins and gut microbiota: the expected slimy partners?

来源: Gut. 2023年72卷12期e7页

446. Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett's oesophagus surveillance: individual-level data analysis.

作者: Emily L Black.;Emma Ococks.;Ginny Devonshire.;Alvin Wei Tian Ng.;Maria O'Donovan.;Shalini Malhotra.;Monika Tripathi.;Ahmad Miremadi.;Adam Freeman.;Hannah Coles.; .;Rebecca C Fitzgerald.
来源: Gut. 2024年73卷5期729-740页
Whether gastric metaplasia (GM) of the oesophagus should be considered as Barrett's oesophagus (BO) is controversial. Given concern intestinal metaplasia (IM) may be missed due to sampling, the UK guidelines include GM as a type of BO. Here, we investigated whether the risk of misdiagnosis and the malignant potential of GM warrant its place in the UK surveillance.

447. Time to focus on the real potential benefit of endobiliary radiofrequency ablation: stent patency in patients with cholangiocarcinoma.

作者: Jeska A Fritzsche.;Esmée Smit.;Cyriel Y Ponsioen.;Rogier P Voermans.
来源: Gut. 2024年73卷10期e11页

448. Antiobesity interventions: options, evidence and value.

作者: Elena B Elkin.;Chin Hur.
来源: Gut. 2024年73卷6期886-887页

449. Impact of climate change on vulnerable populations.

作者: Govind K Makharia.;Anahita Sadeghi.;Desmond Leddin.;Anthony Costello.
来源: Gut. 2023年72卷12期2201-2204页

450. Green gastroenterology adaptation, resilience and an industry perspective.

作者: Cassandra Thiel.;Emma Pak.;Rainer Burkard.;Harald Huber.
来源: Gut. 2023年72卷12期2206-2209页

451. Effects of climate change on digestive health and preventative measures.

作者: Mhairi Claire Donnelly.;Nicholas J Talley.
来源: Gut. 2023年72卷12期2199-2201页

452. Climate change, paediatric health and ways that digestive health professionals can engage.

作者: Rebecca Philipsborn.;Madhumitha Manivannan.;Todd L Sack.
来源: Gut. 2023年72卷12期2216-2218页

453. The fundamentals: understanding the climate change crisis.

作者: Desmond Leddin.;Hugh Montgomery.
来源: Gut. 2023年72卷12期2196-2198页

454. Gastroenterology climate action opportunities via education, empowerment of trainees and research.

作者: Aasma Shaukat.;Brijen Shah.;Cassandra Dl Fritz.;M Bishr Omary.
来源: Gut. 2023年72卷12期2219-2221页

455. World Gastroenterology Organisation - Gut commentary series on digestive health and climate change.

作者: M Bishr Omary.;Desmond Leddin.;Geoffrey Metz.;Andrew M Veitch.;Emad M El-Omar.;Guilherme Macedo.;Mai Ling Perman.
来源: Gut. 2023年72卷12期2193-2196页

456. Approaches for greening endoscopy and reducing waste.

作者: João A Cunha Neves.;Enrique Rodríguez de Santiago.;Lars Aabakken.
来源: Gut. 2023年72卷12期2204-2206页

457. NHS efforts in England to mitigate the climate crisis: uniting nurses and gastroenterologists.

作者: Robin Baddeley.;Nick Watts.;Leigh Donnelly.
来源: Gut. 2023年72卷12期2214-2215页

458. Carbon footprint of gastroenterology practice.

作者: Heiko Pohl.;Robin Baddeley.;Bu'Hussain Hayee.
来源: Gut. 2023年72卷12期2210-2213页

459. Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion.

作者: Yang Wang.;Qiqi Li.;Cheng Li.;Cong Wang.;Shijie Wang.;Wenjie Yuan.;Demin Yu.;Ke Zhang.;Bisheng Shi.;Xiaomei Chen.;Tiantian Liu.;Zhenghong Yuan.;Shuping Tong.;Michael Nassal.;Yu-Mei Wen.;Yong-Xiang Wang.
来源: Gut. 2024年73卷4期668-681页
Chronic hepatitis B (CHB) caused by HBV infection greatly increases the risk of liver cirrhosis and hepatocellular carcinoma. Hepatitis B surface antigen (HBsAg) plays critical roles in the pathogenesis of CHB. HBsAg loss is the key indicator for cure of CHB, but is rarely achieved by current approved anti-HBV drugs. Therefore, novel anti-HBV strategies are urgently needed to achieve sustained HBsAg loss.

460. Practical approach to interpretation of 48-hour wireless pH-monitoring studies.

作者: Amrit K Kamboj.;Yin Chan.;Jason Nasser.;Jane E Lim.;Bianca W Chang.;Ali Rezaie.
来源: Gut. 2024年73卷9期1595页
共有 3428 条符合本次的查询结果, 用时 1.9891999 秒